This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innoviva has snagged a win for its bacterial pneumonia drug Xacduro (durlobactam sodium + sulbactam) with a US Food and Drug Administration FDAapproval for use in patients of ages 18 or older. per share in cash, following a 2020 deal that left the larger pharmacompany with 60% of the latter company’s outstanding shares.
The heart and vascular medication market continues to be a critical focus area for pharmacompanies, with billions of dollars in sales generated annually. Their widespread adoption is driven by strong clinical evidence, broad FDA-approved indications and continued advancements in treatment protocols.
The HIV-focused pharmacompany announced the agency has approved Cabenuva for administration as few as six times a year for adults living with the virus.
Italy-based drugmaker Italfarmaco has won US Food and Drug Administration (FDA) approval for its oral medication Duvyzat (givinostat) for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and older. Duvyzat received Priority Review, Orphan Drug and Rare Pediatric Disease designations from the FDA.
Big pharmacompanies like Pfizer are making significant investments in antibody-drug conjugates, a promising class of therapies. This article explores the growing interest and recent developments, including FDAapprovals and the potential impact on the pharmaceutical industry.
Aprecia Pharmaceuticals’ Spritam, an anti-epileptic drug, is the first and only 3D-printed pharmaceutical, having received US Food and Drug Administration (FDA) approval in 2015. While large pharmacompanies have been slow in this area, Merck and GSK are now using 3D printing for clinical trials and manufacturing.
For the first time in the US, adults living with familial chylomicronemia syndrome (FCS) have an FDA-approved treatment option. The approval of Tryngolza was based on positive results from the Phase III Balance trial, which showed reductions in triglyceride levels and acute pancreatitis events.
Soon they decided that their office in Westin wasn’t good enough for a company with such a sterling reputation, so they spent a massive amount of money building an HQ in Cambridge. They became a big pharmacompany and lost some of the people who made Biogen such great biotech. 4our: The FDA advisors and Aduhelm.
The FDAapproval adds a further treatment avenue to tackle the opioid crisis in the US. Whilst the pharma industry has been relatively slow in developing new treatments – an array of legal challenges posed to pharmacompanies and pharmacies implicated in the crisis still trundles on.
The first, and currently leading, COVID-19 saliva-based test was developed by researchers at Rutgers University, with the test having received FDAapproval back in April. Last month, the FDAapproved a pooled test for COVID-19 developed by Quest Diagnostics. And now it’s getting approval. It’s sensitive.
1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDAapproved once-weekly semaglutide injections. 3hree: Pharma will increase its spending in digital, but a lot of the money will be wasted.
ChemoCentryx has claimed FDAapproval for its avacopan drug for a rare autoimmune disease, becoming the first orally-active drug that targets the complement C5 receptor. Avacopan is already approved in Japan for ANC vasculitis, which causes inflammation in organs including the kidneys, but is sold there by Kissei Pharma.
The top ten pharmacompanies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharmacompanies in 2024 based on 2023 revenue.
Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year. In addition, two more Humira biosimilars are currently under FDA review and both are anticipated to launch in 2023.
SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharmacompanies, according to Indegene. That should, however, not discourage the use of email to HCPs. 100 percent of U.S. ” 2wo: Keep it simple.
Pharmacompanies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. According to the study in JAMA “the FDAapproved 355 new drugs and biologics over the study period. million (95% CI, $683.6
XTALKS WEBINAR: RWD to the Rescue: Solving R&D Challenges for PharmaCompanies Live and On-Demand: Friday, October 25, 2024, at 11am EDT (4pm BST/UK) Register for this free webinar to learn how real-world data (RWD) can enhance the design and execution of clinical trials, leading to more efficient and effective asset strategies.
While private pharmacompanies also take part in such efforts, their efforts has largely been limited to donating assets or distributing treatments. However, some big pharma players have a history of donating some treatments to the cause, he explains. For example, Merck & Co.
To them, a big payday is a small biotech firm being acquired by a big ten pharmacompany. When they tell small biotech companies to cut costs, there will often be a significant delay in getting the drug to market or massive layoffs of needed staff. Venture capitalists often don’t look that far forward.
Ferring Pharmaceuticals announced that the US Food and Drug Administration (FDA) approved Adstiladrin (nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.
Since the frontline treatment setting is dominated by these regimens, pharmacompanies have focused on the development of new drugs in the relapsed/refractory (R/R) setting. lenalidomide) + a steroid ± an anti-CD38 antibody.
The rate of drug approvals could be on the rise. In a recent report, GlobalData revealed that the US Food and Drug Administration (FDA) approved 122 new drug applications (NDAs) and biologic license applications (BLAs) in 2021. There are many reasons why a company might prefer to keep commercialisation activities inhouse.
This strategic move transformed Actavis into one of the largest pharmacompanies globally, with a strong presence across branded, generic and over-the-counter (OTC) medicines. Actavis Acquisition of Allergan Deal value : $70.5
In November 2017, Foundation Medicine received approval for FoundationOne CDx , a genomic profiling test for solid state tumors, which paved the way for partnerships with pharmacompanies’ therapeutics. In 2019, Foundation Medicine and Bayer Healthcare Pharmaceuticals, Inc.
SK Life Science is a subsidiary of SK, a South Korean holding company. GW Pharmaceuticals’ Epidiolex (cannabidiol), the first-FDAapproved CBD treatment , is also a valuable addition, he adds. Epidiolex is approved for Dravet Syndrome, LGS, and tuberous sclerosis complex.
Earlier, the life expectancy of a person with HIV was only one-two years from the time of diagnosis, however, the collaboration of the pharmacompanies and the scientific community have made strides of improvement in the domain. A lot has been achieved in the HIV treatment market sphere.
Its approach involves licensing rights to the antibodies to other pharmacompanies, rather than bringing its own candidates through development. The antibody can be given to adults and children who are at high risk of progressing to severe COVID-19 and/or hospitalisation, according to the FDAapproval.
Consider this example trial: Phase 3 trial completes January 2010 Certification of delayed results obtained December 2010 (compliant) FDAapproval June 2013 Results posted July 2013 (compliant) In looking at the JCO paper's methods section, it really appears that this trial would be classified as reporting results 3.5
Ten months after ChemoCentryx scored an unexpected FDAapproval for autoimmune disease therapy Tavneos, Amgen has swooped in with a $3.7 billion bid to buy out the company. The drug is already approved in Japan for ANC vasculitis, but is sold there by Kissei Pharma, while Otsuka has commercial rights to it in Canada.
Amgen’s Wezlana (ustekinumab-auub) has received US Food and Drug Administration (FDA) approval as a Stelara biosimilar for the treatment of several inflammatory diseases including Crohn’s disease, ulcerative colitis (UC), plaque psoriasis and psoriatic arthritis. This gives it a significant edge over a simple biosimilar designation.
Jazz Pharmaceuticals’ cannabidiol (CBD) drug Epidiolex became the first US Food and Drug Administration (FDA)-approved cannabis-based medication in 2018. The Dublin-based pharmacompany Jazz focuses on developing therapeutics in the neuroscience and oncology spaces.
It’s been developed in collaboration with pharmacompanies to offer a way to incorporate EEG testing in clinical trials much more easily than at present, with the opportunity to harvest much more data over time. The post Cumulus’ gamified dry EEG system tops lab monitoring in trial appeared first on.
Novartis has joined the ranks of big pharmacompanies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharmacompanies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.
Pharmacompanies continue to be among the most profitable industries, even outperforming tech companies. The Pharma Spin. Pharma continues to spin the lie about the high development costs of drugs but an analysis tells us the truth. They found that companies took an average of 7.3
Eyebrows have been raised about the timing of the offer, just ahead of that readout, but Pfizer may be looking to lock in the deal early given interest in Arena among other big pharmacompanies. Pfizer’s bid comes just weeks after it agreed a smaller bolt-on deal to buy immuno-oncology specialist Trillium Therapeutics for $2.3
On the back of the approvals for Pfizer/BioNTech and Moderna, suddenly there is a large amount of interest from big pharmacompanies to get involved in the mRNA space. Pfizer already has a head start on competitors in the field, having achieved the first US FDAapproval for an mRNA vaccine, alongside BioNTech.
Across the industry, pharmacompanies are turning to AI and real-world data to address many of the challenges of running clinical trials. He has worked on Visensia, the world’s first FDA-approved multivariate patient monitoring system, and the SEND system, which is now used to monitor 20,000 patients each month in the NHS.
This novel combination antibiotic treatment is approved for complicated urinary tract infections (cUTIs), including pyelonephritis (a urinary tract infection when one or both kidneys become infected). Efficacy and Safety of Exblifep The FDAapproved Exblifep based on clinical evidence that included the Phase III ALLIUM trial.
The FDA also issued a Rare Pediatric Disease Priority Review Voucher (PRV) to Ipsen that can be used for subsequent drug applications that would not qualify for a priority review. The FDAapproval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release.
Helsinn Group , a Swiss pharma player, is evaluating Anamorelin, an orally active selective ghrelin receptor agonist against Cancer cachexia, The company is conducting Phase III trial to test the efficacy and safety of anamorelin for the treatment of weight loss and anorexia in patients with advanced NSCLC with cachexia.
This changed with the 2017 release of Biogen’s Spinraza, the first FDA-approved therapy for SMA. This, in turn, has driven a need for clinicians to measure disease progression and understand the patient’s disease trajectory better, both prior to treatment and following any treatment approval. About the author.
While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharmacompanies.
Why Pharma Brands Need Social Media Ads Instant Reach With over 4.9 billion social media users worldwide , pharmacompanies can connect with targeted audiences instantly. Ensuring Compliance in Pharma Social Media Ads Navigating regulatory compliance in pharma social media advertising is one of the biggest challenges.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content